Statement from FDA Commissioner Scott Gottlieb, M.D., on 2019 efforts to advance the development of complex generics to improve patient access to medicines
FDA Commissioner on 2019 efforts to advance the development of complex generics to improve patient access to medicines
Source: Food and Drug Administration - Category: American Health Source Type: news
More News: American Health | Food and Drug Administration (FDA)